N&PD Moderators: Skorpio
You should upgrade or use an alternative browser.Reuptake inhibitors (and selectivity)
Selectivity pertaining to what you're probably talking about corresponds to a receptor and/or nuerotransmitterendotropic
Bluelight Crew
And its that simple?
Essentially yes. An SSRI increases the levels of serotonin in the synapse without affecting the other catecholamines (norepinephrine/dopamine). You can compare it to an SNRI (Serotonin/Norepinephrine Reuptake Inhibitor) which will increase levels of serotonin and norepinephrine without affecting dopamine.
A non-selective reuptake inhibitor would be something that increased serotonin, norepinephrine and dopamine.
This isn't entirely correct. All SSRI target and inhibit the serotonin transporter, which takes serotonin out of the synapse. As far as I know the serotonin transporter only has one subtype, so an SSRI can't really be selective here.
Traditional psychedelics (5ht2a agonists) are selective in the way you're talking about, they effect only the serotonin subtype 2a receptor, without targeting the others.Epsilon Alpha
Bluelighter
So suppose a drug inhibits (50% inhibition) SERT at 4nM and NET at 20nM, that means that at a 4nM concentration SERT would be 50% inhibited and NET would be less than 12.5%. The math is a bit more complex than this but you get the picture hopefully.